Alessandro Malara
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Correction: Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis.
Journal: Leukemia
Published: April 01, 2025
Circulating Levels of PF4/CXCL4 in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression.
Journal: Hematological oncology
Published: January 10, 2025
Illustrated capsules from the Advanced Course in Platelet Research.
Journal: Research and practice in thrombosis and haemostasis
Published: November 03, 2024
Dose-dependent effects of eltrombopag iron chelation on platelet formation.
Journal: Blood vessels, thrombosis & hemostasis
Published: July 16, 2024
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis.
Journal: Leukemia
Published: January 18, 2024
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets.
Journal: Current opinion in hematology
Published: August 07, 2023
Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage.
Journal: American journal of human genetics
Published: January 09, 2023
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression.
Journal: Frontiers in oncology
Published: July 06, 2022
Bone marrow microenvironment of MPN cells.
Journal: International review of cell and molecular biology
Published: November 10, 2021
The α2-adrenergic receptor pathway modulating depression influences the risk of arterial thrombosis associated with BDNFVal66Met polymorphism.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 05, 2021
Last Updated: 09/26/2026